Literature DB >> 20439850

Posterior reversible encephalopathy syndrome after rituximab infusion in neuromyelitis optica.

Alejandro Sánchez-Carteyron1, Raquel Alarcia, José Ramón Ara, Jesús Martín.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20439850     DOI: 10.1212/WNL.0b013e3181dc1af3

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  13 in total

1.  [Nervous system side effects of disease modifying treatments of rheumatoid arthritis].

Authors:  A Rubbert-Roth; H-F Petereit
Journal:  Z Rheumatol       Date:  2012-09       Impact factor: 1.372

Review 2.  Update on neuromyelitis optica: natural history and management.

Authors:  Panitha Jindahra; T Plant
Journal:  Eye Brain       Date:  2012-03-26

Review 3.  Posterior reversible encephalopathy syndrome in children with kidney diseases.

Authors:  Kenji Ishikura; Yuko Hamasaki; Tomoyuki Sakai; Hiroshi Hataya; Robert H Mak; Masataka Honda
Journal:  Pediatr Nephrol       Date:  2011-05-11       Impact factor: 3.714

4.  Current and future treatment approaches for neuromyelitis optica.

Authors:  Nicolas Collongues; Jérôme de Seze
Journal:  Ther Adv Neurol Disord       Date:  2011-03       Impact factor: 6.570

5.  Posterior Reversible Encephalopathy Syndrome Secondary to R-CHOP Chemotherapy Regimen.

Authors:  Selim Jennane; El Mehdi Mahtat; Mounir Ababou; Hicham El Maaroufi; Kamal Doghmi
Journal:  Cureus       Date:  2022-05-14

Review 6.  An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica.

Authors:  Nicolas Collongues; Jérôme de Seze
Journal:  Ther Adv Neurol Disord       Date:  2016-03-23       Impact factor: 6.570

7.  Rituximab as a possible cause of posterior reversible encephalopathy syndrome.

Authors:  Ahmed Imran Siddiqi
Journal:  Australas Med J       Date:  2011-09-30

8.  A case of posterior reversible encephalopathy syndrome associated with gilenya(®) (fingolimod) treatment for multiple sclerosis.

Authors:  Hans Lindå; Anders von Heijne
Journal:  Front Neurol       Date:  2015-03-04       Impact factor: 4.003

9.  Acute Respiratory Distress Syndrome and Posterior Reversible Encephalopathy Syndrome following Rituximab Therapy.

Authors:  Katrina E Wardrope; Lynn Manson; Wendy Metcalfe; Eoin D O Sullivan
Journal:  Case Rep Nephrol Dial       Date:  2016-02-24

10.  Neuromyelitis Optica Spectrum Disorder Complicated by Posterior Reversible Encephalopathy Syndrome as an Initial Manifestation.

Authors:  Tomoaki Shima; Shuhei Tsujino; Kairi Yamashita; Takuro Hirayama; Kaori Fukushima; Tadashi Kanamoto; Rie Ohta; Atsushi Nagaoka; Shunsuke Yoshimura; Teiichiro Miyazaki; Yohei Tateishi; Hirokazu Shiraishi; Akira Tsujino
Journal:  Intern Med       Date:  2020-04-23       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.